ClinicalTrials.Veeva

Menu

Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy

University of Michigan logo

University of Michigan

Status

Completed

Conditions

Primary Hyperparathyroidism
Parathyroid Cancer
Hypercalcemia
Parathyroid Neoplasms
Parathyroid Adenoma

Treatments

Other: Standard of Care
Device: PTeye

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05022641
5R01CA212147-02 (U.S. NIH Grant/Contract)
HUM00192089

Details and patient eligibility

About

This study will see if the use of near infrared autofluorescence (NIRAF) detection with an FDA-cleared device 'Parathyroid Eye (PTeye)' for identifying parathyroid glands (PGs) during parathyroidectomy (PTx) procedures is better than a surgeon's detection alone. It compares risk-benefits and outcomes in PTx patients where NIRAF detection with PTeye for parathyroid identification is either used or not used.

Parathyroidectomy - look at application of the technology to see if it assists during a parathyroidectomy.

Full description

Prior to data collection, it was determined some additional outcome measures collected by the primary site would not be relevant to the trial for participating sites such as this site. Those outcomes were removed from this record.

Enrollment

160 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Primary hyperparathyroidism who will be undergoing parathyroid surgery
  • Persistent primary hyperparathyroidism after having undergone a failed prior parathyroid surgery who will be undergoing repeat parathyroid surgery

Exclusion criteria

  • Pregnant women (Those patients who could potentially will receive preoperative pregnancy testing, as is standard before general anesthesia. Any patients with positive pregnancy test results will not be included in the study.)
  • Patients with concurrent parathyroid and thyroid disease that require total thyroidectomy
  • Patients with secondary or tertiary hyperparathyroidism

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

160 participants in 2 patient groups

PTeye
Experimental group
Description:
The surgeon will use the PTeye as an intraoperative tool to identify if a suspect tissue is a parathyroid or not, during the parathyroid surgery.
Treatment:
Device: PTeye
Standard of Care
Other group
Description:
The surgeon will rely solely on her/his surgical experience in identifying the parathyroid glands during the operations.
Treatment:
Other: Standard of Care

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Anee Sophia Jackson

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems